HAEMATOLOGICAL MALIGNANCY
Clinical trials for HAEMATOLOGICAL MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HAEMATOLOGICAL MALIGNANCY trials appear
Sign up with your email to follow new studies for HAEMATOLOGICAL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breast cancer drugs take on rare tumors in new platform trial
Disease control Recruiting nowThis study tests whether two drugs already approved for breast cancer—trastuzumab and pertuzumab—can help people with other rare cancers that have a specific genetic change called HER2 amplification or mutation. About 30 adults, teens, and children with these rare cancers will re…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 01, 2026 20:12 UTC
-
New hope for hard-to-treat blood cancers?
Disease control Recruiting nowThis early-stage trial is testing a new drug called CCS1477 in people with advanced blood cancers such as leukemia, lymphoma, and multiple myeloma. The study aims to see if the drug is safe and can shrink tumors. About 250 participants will receive the drug alone or with other tr…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: CellCentric Ltd. • Aim: Disease control
Last updated May 01, 2026 20:12 UTC
-
Gene-Guided dosing aims to stop deadly fungal infections in cancer patients
Disease control Recruiting nowThis study tests whether using a patient's genetic information to dose the antifungal drug voriconazole can help more patients reach effective drug levels faster. About 104 children and adults with blood cancer and fungal infections will receive either standard dosing or dosing g…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Phase: PHASE2 • Sponsor: The University of Queensland • Aim: Disease control
Last updated May 01, 2026 16:01 UTC